tradingkey.logo
搜尋

Catheter Precision Inc

VTAK
添加自選
0.790USD
-0.085-9.83%
收盤 07/02, 13:00美東報價延遲15分鐘
2.13M總市值
虧損本益比TTM

Catheter Precision Inc

0.790
-0.085-9.83%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-9.83%

5天

-27.52%

1月

-22.55%

6月

-60.70%

今年開始到現在

-56.83%

1年

-82.12%

關鍵數據
0.841今開
0.842最高
252.87K成交量
虧損本益比TTM
--本益比動
--股利TTM
9.39%換手率
0.865昨收
0.780最低
119.08K成交額
虧損本益比靜
0.22市淨率
0.00%股息率 TTM
-51.23%ROA
15.68152週最高
0.70量比
-21.80M淨利潤
2.69M總股本
-10.4776每股盈餘TTM
-1.02Beta
-185.06%ROE
0.75052週最低
7.12%振幅
90.28%毛利率
2.13M總市值
-2.28回報/風險
6.68%風險率

TradingKey Catheter Precision Inc股票評分

單位: USD 更新時間: 2026-07-02

操作建議

Catheter Precision Inc當前公司基本面數據相對謹慎,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名153/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為。最高目標價為38.00。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Catheter Precision Inc評分

相關信息

行業排名
153 / 204
全市場排名
442 / 4565
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Catheter Precision Inc亮點

亮點風險
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
業績高增長
公司營業收入穩步增長,連續3年增長85.29%
業績增長期
公司處於發展階段,最新年度總收入819.00K美元
估值低估
公司最新PE估值-0.08,處於3年歷史低位
機構加倉
最新機構持股304.48K股,環比增加43.06%
活躍度增加
近期活躍度增加,過去20天平均換手率6.93

分析師目標

基於 0 分析師
--
評級
38.000
目標均價
+1753.66%
漲幅空間

Catheter Precision Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Catheter Precision Inc簡介

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
公司代碼VTAK
公司Catheter Precision Inc
CEOJenkins (David A)
網址https://www.ramed.com/

常見問題

Catheter Precision Inc(VTAK)的當前股價是多少?

Catheter Precision Inc(VTAK)的當前股價是 0.79。

Catheter Precision Inc 的股票代碼是什麼?

Catheter Precision Inc的股票代碼是VTAK。

Catheter Precision Inc股票的52週最高點是多少?

Catheter Precision Inc股票的52週最高點是15.68。

Catheter Precision Inc股票的52週最低點是多少?

Catheter Precision Inc股票的52週最低點是0.75。

Catheter Precision Inc的市值是多少?

Catheter Precision Inc的市值是2.13M。

Catheter Precision Inc(VTAK)股票的每股收益(EPS TTM)是多少

Catheter Precision Inc(VTAK)股票的每股收益(EPS TTM)是-15.90。